#VisualAbstract: BRAF/MEK inhibitor therapy may be associated with risk of uveitis in patients with advanced melanoma

byTeddy Guo

February 11, 2021

in StudyGraphics

Reading Time: 1 min read

#VisualAbstract Multiple Cereblon genetic alterations were associated with acquired resistance to lenalidomide or pomalidomide in multiple myeloma

RelatedReports

StudyGraphics

#VisualAbstract: Second-line immunosuppression associated with worse outcomes for immune-related adverse events in melanoma

November 17, 2022

Oncology

First-line treatment with immune checkpoint inhibitor rather than BRAF and MEK leads to improved survival

November 7, 2022

#VisualAbstract: Pembrolizumab provides survival benefit in PD-L1 positive advanced head and neck cancer

StudyGraphics

#VisualAbstract: Nivolumab plus ipilimumab improves recurrence-free survival in patients with resected advanced melanoma

October 20, 2022

The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: World Mental Health Day, Beneath the Band-aid, Trouble in Uganda and Carbon Monoxide Leak Sickens Dozens!

October 18, 2022

Preterm infants responsive to PCV13 vaccine

Increasing vaccine coverage in low and middle-income countries may prevent over 30 million deaths between 2020 to 2030

Complement mutation linked to poor response to eculizumab

Acute neurologic manifestations in children with hemolytic uremic syndrome linked to increased mortality

Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children

Large study outlines risk factors for severe COVID-19 in children

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

#VisualAbstract: BRAF/MEK inhibitor therapy may be associated with risk of uveitis in patients with advanced melanoma

#VisualAbstract: Second-line immunosuppression associated with worse outcomes for immune-related adverse events in melanoma

First-line treatment with immune checkpoint inhibitor rather than BRAF and MEK leads to improved survival

#VisualAbstract: Nivolumab plus ipilimumab improves recurrence-free survival in patients with resected advanced melanoma

#VisualAbstract Multiple Cereblon genetic alterations were associated with acquired resistance to lenalidomide or pomalidomide in multiple myeloma

Increasing vaccine coverage in low and middle-income countries may prevent over 30 million deaths between 2020 to 2030

RelatedReports

#VisualAbstract: Second-line immunosuppression associated with worse outcomes for immune-related adverse events in melanoma

First-line treatment with immune checkpoint inhibitor rather than BRAF and MEK leads to improved survival

#VisualAbstract: Nivolumab plus ipilimumab improves recurrence-free survival in patients with resected advanced melanoma

The Scan by 2 Minute Medicine®: World Mental Health Day, Beneath the Band-aid, Trouble in Uganda and Carbon Monoxide Leak Sickens Dozens!

Increasing vaccine coverage in low and middle-income countries may prevent over 30 million deaths between 2020 to 2030

Acute neurologic manifestations in children with hemolytic uremic syndrome linked to increased mortality

Large study outlines risk factors for severe COVID-19 in children

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2MM+ Premium Access

Recent Reports

Want more physician-written
medical news?

#VisualAbstract: BRAF/MEK inhibitor therapy may be associated with risk of uveitis in patients with advanced melanoma

RELATED REPORTS

#VisualAbstract Multiple Cereblon genetic alterations were associated with acquired resistance to lenalidomide or pomalidomide in multiple myeloma

Increasing vaccine coverage in low and middle-income countries may prevent over 30 million deaths between 2020 to 2030

RelatedReports

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2MM+ Premium Access

Recent Reports

Want more physician-written medical news?

Want more physician-written
medical news?